フロリダ州における円形脱毛症の臨床試験
フロリダ州内の拠点で、円形脱毛症に関する8件の研究が参加者を募集しています。
フロリダ州内の都市
公式研究テキスト（英語）
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Pediatric Skin Research - Miami /ID# 283281, Miami
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/10/02更新 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Health Clinical Research, LLC, Cutler Bay
被験者募集中第2相
18歳〜50歳 · 全性別 · 2026/09/22更新 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Pediatric Skin Research, Miami
- Skin Research of South Florida, Miami
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/18更新 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- James A. Haley Veterans' Hospital, Tampa
被験者募集中第1相
18歳〜70歳 · 全性別 · 2026/09/15更新 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Skin Research of South Florida, Miami
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/10更新 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Skin Care Research Boca Raton /ID# 258012, Boca Raton
- Skin Care Research - Hollywood /ID# 259210, Hollywood
- GSI Clinical Research, LLC /ID# 259352, Margate
- 他2件
被験者募集中第3相
12歳〜63歳 · 全性別 · 2026/08/03更新 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Pediatric Skin Research, Miami
- D&H Tamarac Research Center, Tamarac
被験者募集中第3相
6歳〜14歳 · 全性別 · 2026/04/28更新 · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- D&H Doral Research Center, Doral
- Skin Care Research, Llc - Hollywood, Hollywood
- Ilumina Medical Research Llc, Kissimmee
- 他12件
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/01/28更新 · NCT07133308ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。